Combination drug screen targeting glioblastoma core vulnerabilities reveals pharmacological synergisms https://www.biorxiv.org/content/10.1101/2022.12.14.520491v1?med=mas
Combination drug screen targeting glioblastoma core vulnerabilities reveals pharmacological synergisms https://www.biorxiv.org/content/10.1101/2022.12.14.520491v1?med=mas